13.07.2015 Views

Bavarian Biotech Report 2011/2012 (7MB) - Bio M

Bavarian Biotech Report 2011/2012 (7MB) - Bio M

Bavarian Biotech Report 2011/2012 (7MB) - Bio M

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

MIKROGEN GmbHBIOTECH THERAPEUTICS & DIAGNOSTICSKeywords: Clinical Diagnostics, ELISA / EIA, Infectious Diseases, Automation,Autoimmune Diseases, Chip / Array Technology, PCRFounded in 1989 MIKROGEN GmbH offers innovative solutions for medicallaboratories. The companies scope is the development and production ofclinical diagnostic test systems based on recombinant antigens, with thefocus on bacterial, viral, parasitic and autoimmune diseases. MIKROGEN’score competencies covers genetic engineering and the scientific quality ofresearch and development, which is reflected in various patent applicationsand publications in international journals. The key success factors of thecompany are consistent customer orientation, the strong product competenceand highly skilled employees. MIKROGEN meets ongoing market demandsby emphasising its activities on automation and standardisation in thein-vitro diagnostics, to improve processes in medical laboratories.Contact:Dr. Erwin SoutschekFloriansbogen 2-4D-82061 NeuriedPhone: +49 (0) 89 54801-0Fax: +49 (0) 89 54801-100E-Mail: mikrogen@mikrogen.deInternet: www.mikrogen.deMINITÜB GmbHBIOTECH AGRO, FOOD, ENVIRONMENTKeywords: Artificial Reproduction Technologies, Drug Development,Pharmacokinetics, Transgenic Animals, Cardiovascular Diseases, Diabetics,Respiratory Diseases.Minitüb is an international established system supplier for assisted reproductionof domestic animals, notably in the areas of A.I., cryobiology andE.T. Through its participation in MWM <strong>Bio</strong>models GmbH, a spin-off companyof the LMU Munich, Minitüb is also engaged in the development and characterizationof transgenic large animal models for biomedical research.Current projects are focused on genetically modified pigs for xenotransplantationas well as transgenic pig models of diabetes mellitus, musculardystrophy and immunodeficiency. Customer support starts as early as fromthe design of a project, the development of expression and targeting vectors,the generation of genetically modified large animals, their phenotypiccharacterization, and the performance of preclinical studies.Contact:Dr. Christian SimmetHaupstr. 41D-84184 TiefenbachPhone: +49 (0) 8709 9229-664Fax: +49 (0) 8709 9229-82664E-Mail: csimmet@minitube.deInternet: www.minitube.de87

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!